Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
International Journal of Pharmaceutics: X is Scopus-indexed (Q1, CiteScore 8.9), WoS SCIE, DOAJ. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2590-1567Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 30 / 191 | 84th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q1, CiteScore 8.9.
International Journal of Pharmaceutics: X is Q1 in Pharmaceutical Science (rank 30 of 191), by CiteScore 2025.
International Journal of Pharmaceutics: X is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.9, which places it in quartile Q1 at the 84th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.101, quartile Q1, with an H-index of 37.
The publisher lists an article processing charge of about US$2,590 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
International Journal of Pharmaceutics: X is published by Elsevier B.V. Its ISSN is 2590-1567.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
International Journal of Pharmaceutics: X has an h-index of 39 and a 2-year mean of 3.58 citations per paper (OpenAlex). Its Scopus CiteScore is 8.9, quartile Q1. On 2-year citations it ranks #52 of 177 Scopus journals in Pharmaceutical Science.
International Journal of Pharmaceutics: X published 164 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (52%), Germany (7.9%) and South Korea (5.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 9 retracted papers are recorded (13.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.